Consolidated figures · ₹ crore
| ₹ Cr | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2,065 | 2,202 | 2,095 | 1,915 | 2,052 | 1,945 | 2,707 | 3,999 | 4,430 | 4,078 | |
| COGS | 599 | 411 | 354 | 382 | 511 | 561 | 627 | 717 | 690 | 691 |
| Gross profit | 1,466 | 1,791 | 1,740 | 1,533 | 1,541 | 1,384 | 2,080 | 3,282 | 3,740 | 3,388 |
| 783 | 863 | 946 | 951 | 935 | 1,120 | 1,144 | 1,531 | 1,544 | 1,905 | |
| 683 | 928 | 795 | 583 | 606 | 264 | 936 | 1,751 | 2,196 | 1,483 | |
| OPM % | 33.1% | 42.2% | 38% | 30.4% | 29.5% | 13.6% | 34.6% | 43.8% | 49.6% | 36.4% |
| Depreciation | 54 | 66 | 81 | 100 | 117 | 143 | 164 | 187 | 235 | 207 |
| Interest | 19 | 15 | 19 | 22 | 13 | 18 | 15 | 19 | 24 | 37 |
| 14 | 40 | 130 | 107 | 104 | 99 | 105 | 128 | 355 | 298 | |
| Profit before tax | 624 | 887 | 825 | 569 | 580 | 202 | 862 | 1,674 | 2,291 | 1,537 |
| Tax | 136 | 192 | 182 | 111 | 137 | 32 | 147 | 285 | 408 | 119 |
| Tax % | 21.7% | 21.6% | 22.1% | 19.5% | 23.7% | 15.9% | 17% | 17% | 17.8% | 7.7% |
| 485 | 695 | 642 | 458 | 442 | 170 | 715 | 1,388 | 1,883 | 1,419 | |
| PAT margin % | 23.5% | 31.6% | 30.7% | 23.9% | 21.6% | 8.7% | 26.4% | 34.7% | 42.5% | 34.8% |
| EPS (₹) | — | — | — | 25.3 | 24.2 | 9.3 | 39.2 | 77.3 | 105.3 | 79.2 |
| EPS adjusted (₹) | 27.9 | 37.7 | 35.3 | 25.3 | 24.2 | 9.3 | 39.2 | 77.6 | 105.3 | 79.3 |
| — | — | — | 27.6% | 25.8% | 48.3% | 14% | 12.3% | 5.7% | — | |
| Annual report | Annual report for Mar 2017 | Annual report for Mar 2018 | Annual report for Mar 2019 | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 33 | 35 | 37 | 37 | 36 | 36 | 37 | 37 | 36 | 36 | 36 |
| Reserves | 811 | 1,614 | 3,035 | 3,453 | — | 4,085 | 4,227 | 4,837 | 5,817 | 7,571 | 9,185 |
| Minority interest | — | — | 4 | 2 | — | 2 | — | — | — | 5 | — |
| 274 | 222 | 173 | 387 | — | 266 | 404 | 165 | 363 | 273 | 706 | |
| 264 | 447 | 466 | 425 | — | 403 | 442 | 619 | 690 | 745 | 1,146 | |
| Total equity & liabilities | 1,382 | 2,318 | 3,715 | 4,303 | — | 4,792 | 5,109 | 5,657 | 6,906 | 8,631 | 11,074 |
| 706 | 833 | 1,019 | 1,227 | 1,584 | 2,023 | 2,312 | 2,427 | 2,491 | 2,698 | 2,803 | |
| CWIP | 129 | 336 | 480 | 638 | — | 223 | 130 | 64 | 137 | 225 | 294 |
| Investments | 3 | 32 | 77 | 169 | — | 304 | 308 | 392 | 539 | 474 | 3,127 |
| 543 | 1,116 | 2,140 | 2,270 | — | 2,242 | 2,360 | 2,774 | 3,739 | 5,234 | 4,850 | |
| Total assets | 1,382 | 2,318 | 3,715 | 4,303 | — | 4,792 | 5,109 | 5,657 | 6,906 | 8,631 | 11,074 |
As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed | ROCE % |
|---|---|---|---|---|---|---|
| Pharmaceuticals | 3,940.1 | 1,547.3 | 9,675.9 | 1,491.3 | 8,184.6 | 18.91 |
| Agro chemicals | 138.2 | -19.8 |
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 112 | 346 | 464 | 669 | 417 | 299 | 47 | 849 | 1,212 | 1,697 | 1,768 | |
| -176 | -299 | -1,116 | -612 | -167 | -103 | -5 | -477 | -1,033 | -1,415 | -2,143 | |
| 154 | -48 | 651 | -51 | -251 | -186 | 35 | -363 | -247 | -211 | 298 | |
| Net cash flow | — | -1 | -2 | 6 | -1 | 10 | 76 | 9 | -68 | 72 | -77 |
| Free cash flow | -45 | 67 | 41 | 212 | 62 | 44 | -186 | 703 | 872 | 1,296 | 1,380 |
| CFO / Operating profit % | — | 50.6% | 49.9% | 84.2% | 71.6% | 49.3% | 17.7% | 90.8% | 69.2% | 77.3% | 123.1% |
| 302.2 |
| 52 |
| 250.2 |
| -7.91 |
₹ crore by fiscal year